In late 2013, Congress passed the Drug Quality and Security Act (DQSA) in response to a deadly fungal meningitis outbreak linked to a sterile compounded injectable drug shipped across the country and ...

The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

Joe Cabaleiro is executive director at the Pharmacy Compounding Accreditation Board, a nonprofit dedicated to standards and principles for pharmacy compounding. We asked in a phone interview about the ...

Ever-growing drug shortages are helping compounding pharmacies emerge from the shadows of drugmakers. Meet Mark Jurovich, a prescient pharmacist and co-owner of Juro's Home Medical-Pharmacy in ...

Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss how compounded medications differ from commercially available drugs in terms of their ...

The latest Health Policy Brief from Health Affairs and the Robert Wood Johnson Foundation examines the Compounding Quality Act, a law signed by President Obama in November 2013, which seeks to fill ...

HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, detailing robust growth ...